Genetically predicted 486 blood metabolites concerning risk of systemic lupus erythematosus: a Mendelian randomization study
- PMID: 38110541
- PMCID: PMC10728112
- DOI: 10.1038/s41598-023-49233-8
Genetically predicted 486 blood metabolites concerning risk of systemic lupus erythematosus: a Mendelian randomization study
Abstract
Metabolic abnormalities constitute a significant characteristic of systemic lupus erythematosus (SLE). We utilised a two-sample Mendelian randomisation (MR) study to evaluate the potential causal association between 486 blood metabolites and SLE. Exposure data at the metabolite level were extracted from 7824 European Genome-wide association studies (GWAS). Preliminary analysis utilised SLE GWAS data from FinnGen. The primary method for causal analysis relied on random inverse variance weighting (IVW). To ensure robustness, sensitivity analyses included the Cochran Q test, MR-Egger intercept test, MR-PRESSO, and leave-one-out analysis. Steiger testing and linkage disequilibrium score regression were employed to validate the identified metabolites. This study identified 12 metabolites, comprising six known chemical structures: 1,5-anhydroglucitol(1,5-AG) [odds ratio (OR) = 0.100, 95% confidence interval (CI): 0.015-0.773, P = 0.027), gamma-glutamylthreonine (OR = 0.077, 95% CI: 0.010-0.574, P = 0.012), 5-dodecenoate(12:1n7) (OR = 0.205, 95% CI: 0.061-0.685, P = 0.010), linoleoylglycerophosphoethanolamine * (OR = 0.159, 95% CI: 0.027-0.933, P = 0.044), erythrose (OR = 88.331,95% CI:1.098-63.214, P = 0.040) and 1-, adrenate (22:4n6) (OR = 9.876, 95% CI: 1.753-55.639, P = 0.001)]. Additionally, we found associations between SLE and six unknown chemical structures: X-06351 (OR = 0.071, 95% CI: 0.006-0.817, P = 0.034), X-10810 (OR = 4.268 95% CI: 1.260-14.459, P = 0.020), X-11412 (OR = 5.418 95% CI: 1.068-27.487, P = 0.041), X-11905 (OR = 0.551, 95%CI: 0.304-0.997, P = 0.049), X-12038 (OR = 0.178 95%CI: 0.032-0.988, P = 0.045), X-12217 (OR = 0.174 95%CI: 0.044-0.680, P = 0.014). This study offers evidence supporting a causal relationship between SLE and 12 circulating metabolites, six of which have known chemical structures and six that remain unidentified. These findings introduce a new perspective for further exploration of SLE mechanisms.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study.Clin Rheumatol. 2023 Dec;42(12):3237-3249. doi: 10.1007/s10067-023-06700-x. Epub 2023 Jul 26. Clin Rheumatol. 2023. PMID: 37495778
-
Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study.Cancer Med. 2023 Jun;12(12):13784-13799. doi: 10.1002/cam4.6022. Epub 2023 May 3. Cancer Med. 2023. PMID: 37132247 Free PMC article.
-
Assessment of bidirectional relationships between systemic lupus erythematosus and anxiety disorder: A two-sample Mendelian randomization study.Lupus. 2023 Apr;32(4):471-476. doi: 10.1177/09612033231154784. Epub 2023 Feb 1. Lupus. 2023. PMID: 36722420
-
The Relationship Between Systemic Lupus Erythematosus and Osteoporosis Based on Different Ethnic Groups: a Two-Sample Mendelian Randomization Analysis.Calcif Tissue Int. 2024 Apr;114(4):386-396. doi: 10.1007/s00223-024-01190-8. Epub 2024 Feb 14. Calcif Tissue Int. 2024. PMID: 38355832
-
Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.J Transl Med. 2022 Oct 20;20(1):475. doi: 10.1186/s12967-022-03691-2. J Transl Med. 2022. PMID: 36266699 Free PMC article.
Cited by
-
The role of 1400 plasma metabolites in gastric cancer: A bidirectional Mendelian randomization study and metabolic pathway analysis.Medicine (Baltimore). 2024 Nov 29;103(48):e40612. doi: 10.1097/MD.0000000000040612. Medicine (Baltimore). 2024. PMID: 39612432 Free PMC article.
-
Association between systemic lupus erythematosus and cardiovascular health based on genetic data.Clin Rheumatol. 2025 Jun;44(6):2277-2285. doi: 10.1007/s10067-025-07396-x. Epub 2025 May 3. Clin Rheumatol. 2025. PMID: 40317457
-
Male infertility risk and plasma lipidome: a Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Aug 14;15:1412684. doi: 10.3389/fendo.2024.1412684. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39205681 Free PMC article.
-
Mendelian randomization reveals the causal association between gout and hearing impairment in older adults.Medicine (Baltimore). 2024 May 31;103(22):e38259. doi: 10.1097/MD.0000000000038259. Medicine (Baltimore). 2024. PMID: 39259116 Free PMC article.
-
The effect of inflammatory proteins on COVID-19 is mediated by blood metabolites: A Mendelian randomization study.Medicine (Baltimore). 2025 Mar 14;104(11):e41852. doi: 10.1097/MD.0000000000041852. Medicine (Baltimore). 2025. PMID: 40101060 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical